Dale LC - Search Results

1

Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.

Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, Jiang NS. Lawson GM, et al. Among authors: dale lc. J Clin Pharmacol. 1998 Jun;38(6):510-6. doi: 10.1002/j.1552-4604.1998.tb05788.x. J Clin Pharmacol. 1998. PMID: 9650540 Clinical Trial.

2

Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles.

Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, Hurt RD. Moyer TP, et al. Among authors: dale lc. Clin Chem. 2002 Sep;48(9):1460-71. Clin Chem. 2002. PMID: 12194923

3

Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users.

Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. Ebbert JO, et al. Among authors: dale lc. Addict Behav. 2004 Feb;29(2):349-55. doi: 10.1016/j.addbeh.2003.08.046. Addict Behav. 2004. PMID: 14732423

4

Weight concerns among male smokers.

Clark MM, Decker PA, Offord KP, Patten CA, Vickers KS, Croghan IT, Hays JT, Hurt RD, Dale LC. Clark MM, et al. Among authors: dale lc. Addict Behav. 2004 Nov;29(8):1637-41. doi: 10.1016/j.addbeh.2004.02.034. Addict Behav. 2004. PMID: 15451131 Clinical Trial.

5

Nicotine percentage replacement among smokeless tobacco users with nicotine patch.

Ebbert JO, Post JA, Moyer TP, Dale LC, Schroeder DR, Hurt RD. Ebbert JO, et al. Among authors: dale lc. Drug Alcohol Depend. 2007 Jul 10;89(2-3):223-6. doi: 10.1016/j.drugalcdep.2006.12.034. Epub 2007 Feb 14. Drug Alcohol Depend. 2007. PMID: 17300878 Free PMC article. Clinical Trial.

6

Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.

Ebbert JO, Dale LC, Patten CA, Croghan IT, Schroeder DR, Moyer TP, Hurt RD. Ebbert JO, et al. Among authors: dale lc. Nicotine Tob Res. 2007 Jan;9(1):43-52. doi: 10.1080/14622200601078285. Nicotine Tob Res. 2007. PMID: 17365735 Clinical Trial.

7

Inpatient treatment of severe nicotine dependence.

Hurt RD, Dale LC, Offord KP, Bruce BK, McClain FL, Eberman KM. Hurt RD, et al. Among authors: dale lc. Mayo Clin Proc. 1992 Sep;67(9):823-8. doi: 10.1016/s0025-6196(12)60819-2. Mayo Clin Proc. 1992. PMID: 1434925

8

Nicotine-replacement therapy with use of a transdermal nicotine patch--a randomized double-blind placebo-controlled trial.

Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC. Hurt RD, et al. Among authors: dale lc. Mayo Clin Proc. 1990 Dec;65(12):1529-37. doi: 10.1016/s0025-6196(12)62186-7. Mayo Clin Proc. 1990. PMID: 2255215 Clinical Trial.

9

High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.

Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. Dale LC, et al. JAMA. 1995 Nov 1;274(17):1353-8. JAMA. 1995. PMID: 7563559 Clinical Trial.

10

Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.

Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marŭsić Z, Neese LW, Lundberg TG. Hurt RD, et al. Among authors: dale lc. JAMA. 1994 Feb 23;271(8):595-600. JAMA. 1994. PMID: 8301791 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page